Nara Melikyan - Publications

Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence.

Journal: American journal of epidemiology

Published: October 08, 2025

Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.

Journal: IJTLD open

Published: October 02, 2024

The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 26, 2024

Effectiveness of a bedaquiline, linezolid, clofazimine "core" for multidrug-resistant tuberculosis.

Journal: medRxiv : the preprint server for health sciences

Published: January 31, 2024

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: May 26, 2023

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 15, 2023

Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 28, 2023